Efficacy and Safety of Herbal Medicine (Lianhuaqingwen) for Treating COVID-19: A Systematic Review and Meta-Analysis
LH combined with conventional treatment seems to be more effective for patients with mild or ordinary COVID-19.
Efficacy of Early Combination Therapy With Lianhuaqingwen and Arbidol in Moderate and Severe COVID-19 Patients: A Retrospective Cohort Study
The early combined usage of LHQW and Arbidol may accelerate recovery and improve the prognosis of patients with moderate COVID-19.
Lianhuaqingwen Exerts Anti-Viral and Anti-Inflammatory Activity Against Novel Coronavirus (SARS-CoV-2)
LH significantly inhibits the SARS-COV-2 replication, affects virus morphology and exerts anti-inflammatory activity in vitro. These findings indicate that LH protects against the virus attack, making its use a novel strategy for controlling the COVID-19 disease.
Efficacy and Safety of Lianhua Qingwen Capsule for Influenza: A Systematic Review
Current evidence shows that Lianhua Qingwen capsule is more effective and safer than Oseltamivir, Ribavirin and Ankahuangmin capsules.
Natural Herbal Medicine Lianhuaqingwen Capsule Anti-Influenza A (H1N1) Trial: A Randomized, Double Blind, Positive Controlled Clinical Trial
Compared with Oseltamivir, LHC achieved a similar therapeutic effectiveness reduction of the duration of illness and duration of viral shedding. Therefore, LHC might be an alternative therapeutic measure for influenza A (H1N1) virus infections.